Medicine & TechnologyBioNTech announces its plans on developing a highly effective mRNA-based malaria vaccine after the success of the mRNA COVID-19 vaccine that they co-developed with Pfizer. What could the public expect from this?
In breaking news out of Harvard, researchers announce today they may have identified a crucial link in the deadly chain of malaria infection – the red blood cell’s entry portal for the lethal parasite, Plasmodium falciparum. Their discovery may pave the way for a much anticipated therapy – a vaccine.
The leading malaria vaccine candidate has shown disappointing results, the final study showing that in many cases it simply doesn't work very well and that the initial protection fades with time.